A) In women with osteoporosis or low bone mass (osteopenia) or those with ‘normal’ bones |
QUI Sahara® |
|
|
16.777 |
<0.001* |
|
|
|
|
OP |
49 |
71.3±11.3 |
|
|
“OP” vs. “OPN” |
0.003f |
-15.17 |
-2.67 |
OPN |
45 |
80.2±11.5 |
|
|
“OP ” vs. “NML” |
<0.001f |
-22.50 |
-9.32 |
NML |
37 |
87.2±15.7 |
|
|
“OPN” vs. “NML” |
0.039f |
-13.71 |
-0.28 |
QUI T-score Sahara® |
|
|
16.846 |
<0.001* |
|
|
|
|
OP |
49 |
-1.85±0.64 |
|
|
“OP” vs. “OPN” |
0.004f |
-0.64 |
-0.14 |
OPN |
45 |
-1.36±0.65 |
|
|
“OP ” vs. “NML” |
<0.001f |
-1.28 |
-0.53 |
NML |
37 |
-0.94±0.89 |
|
|
“OPN” vs. “NML” |
0.029f |
0.14 |
0.84 |
BUA Sahara® |
|
|
18.308 |
<0.001** |
|
|
|
|
OP |
49 |
57.1±11.1 |
|
|
“OP” vs. “OPN” |
0.001$ |
- |
- |
OPN |
45 |
63.7±10.1 |
|
|
“OP ” vs. “NML” |
<0.001$ |
- |
- |
NML |
37 |
69.2±14.3 |
|
|
“OPN” vs. “NML” |
0.119$ |
- |
|
SOS Sahara® |
|
|
18.465 |
<0.001* |
|
|
|
|
OP |
49 |
1508.8±17.8 |
|
“OP” vs. “OPN” |
0.003f |
-24.36 |
-4.23 |
OPN |
45 |
1523.1±19.1 |
|
“OP ” vs. “NML” |
<0.001f |
-37.65 |
-16.41 |
NML |
37 |
1535.9±25.2 |
|
“OPN” vs. “NML” |
0.017f |
-23.56 |
-1.92 |
eBMD Sahara® |
|
|
16.507 |
<0.001* |
|
|
|
|
OP |
49 |
0.375±0.072 |
|
“OP” vs. “OPN” |
0.004f |
-0.093 |
-0.015 |
OPN |
45 |
0.429±0.072 |
|
“OP ” vs. “NML” |
<0.001f |
-0.141 |
-0.058 |
NML |
37 |
0.475±0.099 |
|
“OPN” vs. “NML” |
0.030f |
-0.088 |
-0.004 |
Radial SOS Sunlight Omnisense® |
|
5.429 |
0.005* |
|
|
|
|
OP |
49 |
4042.7±162.2 |
|
|
“OP” vs. “OPN” |
0.139f |
-137.4 |
14.7 |
OPN |
45 |
4104.0±152.4 |
|
|
“OP ” vs. “NML” |
0.004f |
-190.5 |
-30.0 |
NML |
37 |
4152.9±149.6 |
|
|
“OPN” vs. “NML” |
0.334f |
-130.7 |
32.8 |
Tibial SOS Sunlight Omnisense® |
|
3.540 |
0.032* |
|
|
|
|
OP |
|
3726.0±129.3 |
|
|
“OP” vs. “OPN” |
0.948f |
-75.95 |
58.26 |
OPN |
45 |
3734.9±156.2 |
|
|
“OP ” vs. “NML” |
0.037f |
-145.31 |
-3.74 |
NML |
37 |
3800.6±121.3 |
|
|
“OPN” vs. “NML” |
0.082f |
-137.81 |
6.45 |
Phalangeal SOS Sunlight Omnisense® OP |
28 |
3952.0±243.3 |
0.438 |
0.647* |
“OP” vs. “OPN” |
NA |
|
|
OPN |
45 |
3939.8±230.3 |
|
|
“OP ” vs. “NML” |
NA |
- |
- |
NML |
37 |
4015.4±256.7 |
|
|
“OPN” vs. “NML” |
NA |
- |
- |
B) In men with osteoporosis or low bone mass |
QUI Sahara® |
|
|
14.680 |
0.001** |
|
|
|
|
OP |
37 |
77.2±10.8 |
|
|
“OP” vs. “OPN” |
0.001## |
- |
- |
OPN |
36 |
87.5±13.9 |
|
|
“OP ” vs. “NML” |
0.001## |
- |
- |
NML |
36 |
87.1±16.8 |
|
|
“OPN” vs. “NML” |
0.366## |
- |
- |
QUI T-score Sahara® |
|
|
14.869 |
0.001** |
|
|
|
|
OP |
37 |
-1.82±0.63 |
|
|
“OP” vs. “OPN” |
0.001## |
- |
- |
OPN |
36 |
-1.20±0.83 |
|
|
“OP ” vs. “NML” |
0.001## |
- |
- |
NML |
36 |
-1.22±0.99 |
|
|
“OPN” vs. “NML” |
0.309## |
- |
- |
BUA Sahara® |
|
|
7.845 |
0.020** |
|
|
|
|
OP |
37 |
65.7±10.7 |
|
|
“OP” vs. “OPN” |
0.013## |
- |
- |
OPN |
36 |
73.2±10.9 |
|
|
“OP ” vs. “NML” |
0.026## |
- |
- |
NML |
36 |
70.8±16.9 |
|
|
“OPN” vs. “NML” |
0.456## |
- |
- |
SOS Sahara® |
|
|
17.023 |
<0.001** |
|
|
|
|
OP |
37 |
1513.8±16.4 |
|
“OP” vs. “OPN” |
0.001## |
- |
- |
OPN |
36 |
1532.2±23.5 |
|
“OP ” vs. “NML” |
<0.001## |
- |
- |
NML |
36 |
1533.4±26.1 |
|
“OPN” vs. “NML” |
0.244## |
- |
- |
eBMD Sahara® |
|
|
15.537 |
<0.001** |
|
|
|
|
OP |
37 |
0.410±0.067 |
|
“OP” vs. “OPN” |
0.001## |
- |
- |
OPN |
36 |
0.477±0.088 |
|
“OP ” vs. “NML” |
0.001## |
- |
- |
NML |
36 |
0.474±0.106 |
|
“OPN” vs. “NML” |
0.366## |
- |
- |
Radial SOS Sunlight Omnisense® |
|
0.043 |
0.958* |
|
|
|
|
OP |
37 |
4052.2±228.9 |
|
|
“OP” vs. “OPN” |
NA |
- |
- |
OPN |
36 |
4061.6±131.6 |
|
|
“OP ” vs. “NML” |
NA |
- |
- |
NML |
36 |
4063.3±146.8 |
|
|
“OPN” vs. “NML” |
NA |
- |
- |
Tibial SOS Sunlight Omnisense® |
|
1.507 |
0.226* |
|
|
|
|
OP |
37 |
3846.8±113.4 |
|
|
“OP” vs. “OPN” |
NA |
- |
- |
OPN |
36 |
3886.1±104.4 |
|
|
“OP ” vs. “NML” |
NA |
- |
- |
NML |
36 |
3884.2±109.8 |
|
|
“OPN” vs. “NML” |
NA |
- |
- |
Phalangeal SOS Sunlight Omnisense® OP |
32 |
3958.3±162.7 |
0.050 |
0.952* |
“OP” vs. “OPN” |
NA |
|
|
OPN |
31 |
3944.9±169.1 |
|
|
“OP ” vs. “NML” |
NA |
- |
- |
NML |
32 |
3951.3±174.3 |
|
“OPN” vs. “NML” |
NA |
- |
- |
ANOVA: Analysis of Variance; QUS: Quantitative ultrasound; QUI: Quantitative Ultrasound Index; SD: Standard deviation; OP: Osteoporosis; OPN: Osteopenia; NML: Normal;BUA: Broadband ultrasound attenuation; SOS: Speed of sound; eBMD: Estimated heel bone mineral density; NA: Not applicable; p values for * ANOVA test; ** Kruskal-Wallis test, f Tukey test; $ Mann-Whitney U test. |